Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Interventricular Delay of Lumax HF-T for Heart Failure

ClinicalTrials.gov ID: NCT00508391

Public ClinicalTrials.gov record NCT00508391. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 1, 2026, 10:13 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Clinical Investigation to Study Safety and Efficacy of the Interventricular Delay Feature of the Lumax HF-T Device for Heart Failure.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to demonstrate that the safety and efficacy of the Lumax HF-T with optimized interventricular delay biventricular pacing (OPT) is non-inferior to the Lumax HF-T with simultaneous biventricular pacing (SIM) in patients with heart failure requiring cardiac resynchronization therapy.

Study identification

NCT ID
NCT00508391
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Biotronik, Inc.
Industry
Enrollment
122 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2007
Primary completion
Nov 30, 2008
Completion
Jul 31, 2009
Last update posted
Jan 25, 2010

2007 – 2009

United States locations

U.S. sites
18
U.S. states
10
U.S. cities
17
Facility City State ZIP Site status
Solano Cardiology Fairfield California 94533
Cardiac Arrhythmia Associates La Jolla California 92307
Sansum Clinic Santa Barbara California 93110
Cardiology Associates Medical Group Ventura California 93003
Cardiac Disease Specialists, P.C. Atlanta Georgia 30309
Georgia Arrhythmia Consultants Macon Georgia 31201
Fananapazir Cumberland Maryland 21502
St. Elizabeth's Medical Center Boston Massachusetts 02135
Michigan Cardiovascular Institute Saginaw Michigan 48601
SSM Medical Group St Louis Missouri 63117
Gateway Cardiology St Louis Missouri 63128
Salem Cardiology Salem Oregon 97302
Palmetto Cardiology Columbia South Carolina 29204
Pee Dee Cardiology Florence South Carolina 29505
Cardiology Consultants Spartanburg South Carolina 29303
Lone Star Heart Center Amarillo Texas 79106
Cardiac Associates of Dallas Dallas Texas 75230
Yakima Heart Center Yakima Washington 98902

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00508391, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 25, 2010 · Synced Sep 1, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00508391 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →